NCT04013269View on ClinicalTrials.gov

Adjuvant Therapy With CytoSorb in Refractory Septic Shock

NAUnknownINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions

Septic Shock

Interventions

DEVICE

CytoSorb-Therapy

Additional use of Cytosorb-Adsorber in patients with septic shock and need for continuous renal replacement therapy

Trial Locations (1)

Unknown

RECRUITING

University Medical Center Hamburg-Eppendorf, Hamburg

Sponsors

Collaborators (1)

CytoSorbents, Inc

All Listed Sponsors

collaborator

CytoSorbents, Inc

INDUSTRY

lead

Universitätsklinikum Hamburg-Eppendorf

OTHER